119 related articles for article (PubMed ID: 31687164)
1. Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations.
Ohno Y; Seki T; Kojima Y; Miki R; Egawa Y; Hosoya O; Kasono K; Seki T
J Pharm Health Care Sci; 2019; 5():22. PubMed ID: 31687164
[TBL] [Abstract][Full Text] [Related]
2. Differences in interaction lead to the formation of different types of insulin amyloid.
Mori W; Kawakami R; Niko Y; Haruta T; Imamura T; Shiraki K; Zako T
Sci Rep; 2022 May; 12(1):8556. PubMed ID: 35595809
[TBL] [Abstract][Full Text] [Related]
3. Precipitation of insulin products used for continuous subcutaneous insulin infusion.
Poulsen C; Langkjaer L; Worsøe C
Diabetes Technol Ther; 2005 Feb; 7(1):142-50. PubMed ID: 15738712
[TBL] [Abstract][Full Text] [Related]
4. Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release.
Weber C; Kammerer D; Streit B; Licht AH
Toxicol Rep; 2015; 2():194-202. PubMed ID: 28962351
[TBL] [Abstract][Full Text] [Related]
5. Precipitation of insulin aspart and insulin glulisine products used for continuous subcutaneous insulin infusion.
Poulsen C; Langkjaer L; Worsøe C
Diabetes Technol Ther; 2007 Feb; 9(1):26-35. PubMed ID: 17316095
[TBL] [Abstract][Full Text] [Related]
6. ON THE FORMATION OF PRECIPITATES AFTER THE INTRAVENOUS INJECTION OF SALVARSAN.
Joseph DR
J Exp Med; 1911 Jul; 14(1):83-98. PubMed ID: 19867454
[TBL] [Abstract][Full Text] [Related]
7. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
DeFelippis MR; Bell MA; Heyob JA; Storms SM
Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion versus multiple daily injections.
Karagianni P; Sampanis Ch; Katsoulis Ch; Miserlis G; Polyzos S; Zografou I; Stergiopoulos S; Douloumbakas I; Zamboulis Ch
Hippokratia; 2009 Apr; 13(2):93-6. PubMed ID: 19561778
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
10. Insulin, Not the Preservative m-cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine.
Swinney MR; Cox AL; Hawkins ED; Xue J; Garhyan P; Stanley JRL; Sule SV; Adragni K; Michael MD
J Pharm Sci; 2021 Mar; 110(3):1418-1426. PubMed ID: 33321138
[TBL] [Abstract][Full Text] [Related]
11. Buffer capacity and precipitation control of pH solubilized phenytoin formulations.
Alvarez-Núñez FA; Yalkowsky SH
Int J Pharm; 1999 Aug; 185(1):45-9. PubMed ID: 10425364
[TBL] [Abstract][Full Text] [Related]
12. Dynamic compatibility testing of DMP 840, an experimental antitumor agent.
Rubino JT; Nellore R; Parmar B
PDA J Pharm Sci Technol; 1997; 51(3):130-6. PubMed ID: 9203827
[TBL] [Abstract][Full Text] [Related]
13. Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.
Mori W; Yuzu K; Lobsiger N; Nishioka H; Sato H; Nagase T; Iwaya K; Lindgren M; Zako T
Sci Rep; 2021 Mar; 11(1):6857. PubMed ID: 33767265
[TBL] [Abstract][Full Text] [Related]
14. Defining the right diluent for intravenous infusion of therapeutic antibodies.
Luo S; McSweeney KM; Wang T; Bacot SM; Feldman GM; Zhang B
MAbs; 2020; 12(1):1685814. PubMed ID: 31774346
[TBL] [Abstract][Full Text] [Related]
15. Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy.
Kawamura T; Urakami T; Sugihara S; Kim HS; Mochizuki M; Amamiya S
Clin Pediatr Endocrinol; 2008; 17(2):39-47. PubMed ID: 24790361
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Novel Insulin Fibrils That Show Strong Cytotoxicity Under Physiological pH.
Yoshihara H; Saito J; Tanabe A; Amada T; Asakura T; Kitagawa K; Asada S
J Pharm Sci; 2016 Apr; 105(4):1419-26. PubMed ID: 27019958
[TBL] [Abstract][Full Text] [Related]
17. Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitus.
Brownlee M; Vlassara H; Cerami A; Martin TR; Li JJ; McAdam KP
Lancet; 1984 Feb; 1(8374):411-3. PubMed ID: 6142148
[TBL] [Abstract][Full Text] [Related]
18. [Precipitation of piritramide and cefazolin. Study of the dependence on concentration and pH].
Eckle VS; Grasshoff C
Anaesthesist; 2013 Nov; 62(11):898-901. PubMed ID: 24220788
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
Alemzadeh R; Parton EA; Holzum MK
Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
[TBL] [Abstract][Full Text] [Related]
20. Insulin precipitation in artificial infusion devices.
James DE; Jenkins AB; Kraegen EW; Chisholm DJ
Diabetologia; 1981 Dec; 21(6):554-7. PubMed ID: 6802694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
